ADHD drug tested as potential Weight-Loss aid for kids
NCT ID NCT05416125
Summary
This study is testing whether adding the medication lisdexamfetamine to standard lifestyle therapy helps children with severe obesity lose more weight. Children aged 6 to 12 will be randomly assigned to receive either the medication or a placebo, along with lifestyle coaching, for 24 weeks. The main goal is to see which group has a greater reduction in their body mass index (BMI).
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY, CHILDHOOD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55414, United States
Conditions
Explore the condition pages connected to this study.